整個手腕置換市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)
Total Wrist Replacement Market - Growth, Trends, and Forecasts (2023 - 2028)
在預測期內，整個腕關節置換市場預計將以 3.5% 的複合年增長率增長。
COVID-19 的爆發對整個腕關節置換市場產生了重大影響。 這是由於在大流行的早期階段對選擇性和非緊急手術實施了嚴格的規定。 例如，2022 年 1 月發表在 Bone and Joint Open 上的一篇論文指出，與 2021 年相比，手部和創傷服務減少了 32%，手部創傷手術減少了 41%。事實一直如此。 大流行期間手術量和患者湧入的減少對市場產生了顯著影響。 然而，在放寬嚴格的封鎖程序後，大流行後時期手腕手術的恢復預計將有助於市場的增長。
推動整個腕關節置換市場增長的主要因素是人口老齡化加劇、類風濕性關節炎和骨關節炎患病率增加以及骨折和事故數量增加。 例如，根據 2022 年 9 月發表的 NCBI 文章，北歐和北美類風濕性關節炎的發病率分別為每 10 萬人 24 例和 36 例。 同樣，2021 年發表的另一篇 NCBI 論文指出，2021 年全球骨關節炎患病率將增加 8.5% 至 9.3%。 論文還指出，2021 年骨關節炎的區域患病率北美為 22.5%，西歐為 7.2%，中亞為 8.4%，北中東和非洲為 12.8%。 骨關節炎和類風濕性關節炎的流行預計將推動全腕置換手術的需求，並在預測期內促進市場增長，因為它增加了腕關節置換的可能性。
另一方面，預計產品開發和批准的增加將推動預測期內所研究市場的增長。 例如，2021 年 5 月，骨科植入物公司宣布美國食品和藥物管理局批准並商業推出其腕部骨折電鍍技術 DRPx 系統。 此外，在 2021 年 5 月，特殊外科醫院的外科醫生開發了一種手腕植入物 KninematX，這是一種全手腕置換系統。 同一位外科醫生還用這種植入物進行了腕關節置換手術。
全腕關節置換術，也稱為全腕關節置換術 (TWF)，是一種通過融合前臂骨骼和腕小骨來穩定或固定腕關節的外科手術。 該手術可減輕嚴重手腕受傷後的疼痛。 如果休息、藥物、注射和物理治療等保守治療不能緩解疼痛，醫生可能會建議進行全腕關節置換術。
隨著容易患關節炎的老年人口增加以及手臂受傷的增加，預計在整個預測期內，全腕關節置換手術的使用將保持健康的需求和供應。 例如，根據世界衛生組織2021年10月的報告，60歲以上的人口預計將從2020年的10億增長到2050年的21億，老年人更容易患關節炎和癌症。由於由於對骨質疏鬆症等肌肉骨骼疾病的易感性，預計在整個預測期內對全腕融合手術的需求將增加。 此外，骨關節炎被認為是65歲以上人群中最常見的關節疾病之一。 因此，預計老年人口的增加將推動對全腕融合的需求，從而促進研究領域的增長。
此外，主要參與者正在努力開發新穎的產品和技術。 例如，2021 年 10 月，Tyber Medical LLC 宣布其擴展的解剖電鍍系統系列（包括手腕固定板）已獲得美國食品和藥物管理局的許可。 此外，2021 年 9 月，全球聯合保存公司 Anika Therapeutics, Inc. 將在舊金山舉行的 ASSH（美國手外科學會）2021 年年會上展示 WristMotionTotal Wrist Arthroplasty (TWA) 系統。宣布它已經發布。
例如，2022 年 7 月在 NCBI 發表的一篇論文指出，美國大約每 7 人中就有 1 人患有腕關節炎，到 2022 年將達到該國人口的 13.6%。事實已經如此。 同樣，俄亥俄州立大學 2021 年的一篇論文報告稱，美國每年有 600 萬人遭受骨折之苦。 文章還指出，骨折占美國每年肌肉骨骼損傷的 16%。 超過 40% 的骨折發生在家中。 同樣，2021 年 1 月發表的一篇 NCBI 文章指出，到 2021 年，超過 16.5% 的加拿大人（約 480 萬人）將被衛生專業人員診斷出患有各種形式的關節炎。 因此，關節炎和骨折發病率的增加預計將推動北美對全腕關節置換手術的需求，推動市場增長。
此外，該地區手腕置換手術總數的增加預計將為該地區提供有利可圖的機會，從而推動市場增長。 例如，2021 年 4 月，Extremity Medical 公佈了首例使用 KinematX 全腕置換裝置的手術病例。 KinematX 是一種掌骨植入物，旨在模仿腕關節炎患者和其他人的自然運動範圍。
市場競爭激烈，進入市場的公司眾多，因此比較分散。 該市場的主要參與者包括 Zimmer Biomet、Integra Lifesciences Holdings Corporation、Johnson and Johnson、Stryker Corporation 和 Acumed LLC。
The total wrist replacement market is expected to register a CAGR of 3.5% over the forecast period.
The outbreak of COVID-19 has significantly impacted the total wrist replacement market. This was due to the strict regulations imposed on elective and non-urgent surgeries during the initial stages of the pandemic. For instance, the article published in Bone and Joint Open journal in January 2022 mentioned a 32% reduction in hand and trauma services, and the surgical procedures on hand trauma were reduced by 41% compared to 2021. Such reduction in the surgical volume and patient inflow during the pandemic had a notable impact on the market. However, the resumption of wrist surgeries during the post-pandemic period after the relaxation of strict lockdown procedures is expected to contribute to the market's growth.
The key factors propelling the growth of the total wrist replacement market are the increasing aging population, the increasing prevalence of rheumatoid and osteoarthritis, and the increase in fracture and accident cases. For instance, according to the NCBI article published in September 2022, the incidence of rheumatoid arthritis in Northern Europe and Northern America was 24 and 36 cases per 100,000 people, respectively. Similarly, another NCBI article published in 2021 mentioned that globally, osteoarthritis prevalence increased by 8.5%-9.3% in 2021. The article also mentioned that the regional prevalence of osteoarthritis was 22.5% in North America, 7.2% in Western Europe, 8.4% in Central Asia, and 12.8% in North Africa and the Middle East in 2021. Such prevalence of osteoarthritis and rheumatoid arthritis, which increase the possibility of wrist replacement, is expected to drive the demand for total wrist replacement, thereby contributing to the market's growth over the forecast period.
On the other hand, rising product developments and approvals are expected to drive the growth of the studied market over the forecast period. For instance, in May 2021, the Orthopaedic Implant Company announced the United States Food and Drug Administration clearance and commercial launch of its wrist fracture plating technology, the DRPx System. Additionally, in May 2021, Hospital for Special Surgery surgeon developed a wrist implant, KninematX, total wrist arthroplasty system. The surgeon also performed wrist-replacement surgery using this implant.
However, the high costs involved in wrist reconstruction surgeries are expected to hinder market growth during the forecast period.
Total wrist arthrodesis, also known as total wrist fusion (TWF), is a surgical procedure in which the wrist joint is stabilized or immobilized by fusing the forearm bone with the small bones of the wrist. This procedure relieves the pain after severe trauma to the wrist. The doctor may recommend total wrist arthrodesis when conservative treatments such as rest, medications, injections, and physical therapy do not relieve the pain.
With the growing geriatric population prone to develop arthritis and increasing arm injury, the use of total wrist fusion is expected to observe healthy demand and supply throughout the forecast period. For instance, as per the October 2021 report of the World Health Organization, the population of people of age 60 years or more is expected to increase from 1 billion in 2020 to 2.1 billion by 2050, and as the older population is more prone to musculoskeletal disorders, such as arthritis and osteoporosis, the demand for total wrist fusion is expected to increase over the forecast period. Moreover, osteoarthritis is considered one of the most prevalent articular diseases among the population above the age of 65 years. Thus, the rising geriatric population is expected to drive the demand for total wrist fusion, thereby contributing to the growth of the studied segment.
Additionally, major players are engaged in the development of novel products and technologies. For instance, in October 2021, Tyber Medical LLC announced it had received the United States Food and Drug Administration clearance for its expanded line of anatomical plating systems, including wrist fusion plates. Moreover, in September 2021, Anika Therapeutics, Inc., a global joint preservation company, announced its WristMotionTotal Wrist Arthroplasty (TWA) System was launched at the American Society for Surgery of the Hand (ASSH) 2021 annual meeting in San Francisco.
North America is expected to hold a major share of the total wrist replacement market and is expected to show the same trend over the forecast period. The rising arthritis cases along with increasing arm injuries in this region along with the presence of major market players are expected to contribute to the growth of the market in this region.
For instance, the article published in NCBI in July 2022, mentioned that about one in seven people had wrist arthritis in the United States which was 13.6% of the country's population in 2022. Similarly, an article published by the Ohio State University, in 2021, reported that 6 million people in the United States broke a bone each year. The article also mentioned that fractures account for 16% of all musculoskeletal injuries in the United States annually. More than 40% of fractures occur at home. Likewise, the NCBI article published in January 2021, mentioned that over 16.5% of Canadians, around 4.8 million people had been diagnosed with various forms of arthritis by health professionals in 2021. Therefore, the increasing incidence of arthritis and bone fractures is expected to drive the demand for total wrist replacement in North America, thereby fueling the growth of the market.
Also, the rising total wrist replacement surgeries in this region is expected to provide lucrative opportunities in this region, thereby driving the growth of the market. For instance, in April 2021, Extremity Medical announced the first surgical case using KinematX total wrist device. KinematX is a mid carpal implant designed to mimic the natural range of motion in patients with wrist arthritis and others.
Thus, the rising arthritis cases along with the increasing adoption of total wrist replacement surgeries among the population is expected to contribute to the growth of the market in this region.
The market studied is moderately competitive and fragmented due to many market players. Some major players in this market include Zimmer Biomet, Integra Lifesciences Holdings Corporation, Johnson and Johnson, Stryker Corporation, and Acumed LLC, among others.